AAPL334.51+2.24 (+0.67%) ▲|ABBV261.43+4.31 (+1.68%) ▲|ABT102.95+1.00 (+0.98%) ▲|ACN194.28+10.38 (+5.64%) ▲|ADBE264.86+12.63 (+5.01%) ▲|AMAT426.96-29.53 (-6.47%) ▼|AMD494.09-22.05 (-4.27%) ▼|AMGN380.37+3.02 (+0.80%) ▲|AMT177.20-0.65 (-0.37%) ▼|AMZN255.59-1.19 (-0.46%) ▼|AVGO346.64-15.36 (-4.24%) ▼|AXP326.91+2.22 (+0.68%) ▲|BA210.37-0.09 (-0.04%) ▼|BAC60.11-2.59 (-4.12%) ▼|BKNG175.20+1.28 (+0.74%) ▲|BLK1,066.89-12.76 (-1.18%) ▼|BMY64.12+0.48 (+0.75%) ▲|BNY158.30-4.36 (-2.68%) ▼|BRK-B513.81+3.44 (+0.67%) ▲|C133.83-4.99 (-3.59%) ▼|CAT786.08-32.50 (-3.97%) ▼|CL88.34+1.54 (+1.77%) ▲|CMCSA24.98-0.22 (-0.87%) ▼|COF207.37-0.94 (-0.45%) ▼|COP137.69+0.34 (+0.25%) ▲|COST917.05+12.28 (+1.36%) ▲|CRM258.90+11.18 (+4.51%) ▲|CSCO111.49-0.65 (-0.58%) ▼|CVS95.67+1.01 (+1.07%) ▲|CVX213.68-0.39 (-0.18%) ▼|DE681.39+5.65 (+0.84%) ▲|DHR203.41+3.27 (+1.63%) ▲|DIS109.18+2.63 (+2.47%) ▲|DUK118.88-0.54 (-0.45%) ▼|EMR148.37-3.82 (-2.51%) ▼|FDX311.61+0.84 (+0.27%) ▲|GD356.78+0.88 (+0.25%) ▲|GE317.29-6.38 (-1.97%) ▼|GEV873.25-84.02 (-8.78%) ▼|GILD145.74+2.02 (+1.41%) ▲|GM86.41+0.79 (+0.92%) ▲|GOOG345.45+10.00 (+2.98%) ▲|GOOGL348.92+10.42 (+3.08%) ▲|GS990.42-38.76 (-3.77%) ▼|HD310.54+1.80 (+0.58%) ▲|HON199.12-3.25 (-1.60%) ▼|IBM250.89+7.60 (+3.12%) ▲|INTC98.29-4.66 (-4.52%) ▼|INTU338.38+16.81 (+5.23%) ▲|ISRG376.21+7.06 (+1.91%) ▲|JNJ267.88+2.30 (+0.87%) ▲|JPM349.21-7.02 (-1.97%) ▼|KO89.14+0.85 (+0.96%) ▲|LIN464.53-1.70 (-0.36%) ▼|LLY1,145.82+30.12 (+2.70%) ▲|LMT527.84+3.65 (+0.70%) ▲|LOW198.37+1.55 (+0.79%) ▲|LRCX275.82-22.41 (-7.51%) ▼|MA575.04+5.85 (+1.03%) ▲|MCD257.19+4.66 (+1.85%) ▲|MDLZ62.38-0.06 (-0.10%) ▼|MDT93.31+2.35 (+2.58%) ▲|META664.45+16.42 (+2.53%) ▲|MMM162.01-2.96 (-1.79%) ▼|MO70.55+1.57 (+2.27%) ▲|MRK145.46+1.53 (+1.06%) ▲|MS207.18-7.21 (-3.36%) ▼|MSFT509.20+13.57 (+2.74%) ▲|MU926.10-49.17 (-5.04%) ▼|NEE82.21-0.10 (-0.12%) ▼|NFLX80.75+3.35 (+4.32%) ▲|NKE37.15+0.35 (+0.94%) ▲|NOW143.13+10.60 (+7.99%) ▲|NVDA212.42-5.88 (-2.69%) ▼|ORCL143.85-6.44 (-4.28%) ▼|PEP136.61+0.29 (+0.21%) ▲|PFE27.78+0.06 (+0.20%) ▲|PG146.24+0.97 (+0.67%) ▲|PLTR173.30+6.07 (+3.63%) ▲|PM193.93+2.87 (+1.50%) ▲|QCOM179.12-2.85 (-1.57%) ▼|RTX194.66-3.03 (-1.53%) ▼|SBUX98.86+0.12 (+0.12%) ▲|SCHW106.98-0.27 (-0.25%) ▼|SO86.85-0.33 (-0.37%) ▼|SPG204.76-0.08 (-0.04%) ▼|T26.44+0.38 (+1.46%) ▲|TMO612.15+2.33 (+0.38%) ▲|TMUS183.99+1.66 (+0.91%) ▲|TSLA362.69-2.75 (-0.75%) ▼|TXN264.64-4.06 (-1.51%) ▼|UBER72.76+1.09 (+1.52%) ▲|UNH384.33+7.56 (+2.01%) ▲|UNP284.54+0.14 (+0.05%) ▲|UPS101.69+1.41 (+1.41%) ▲|USB62.38-0.46 (-0.73%) ▼|V376.34+5.89 (+1.59%) ▲|VZ51.30+0.69 (+1.35%) ▲|WFC87.69-2.60 (-2.88%) ▼|WMT109.49+2.34 (+2.18%) ▲|XOM165.46-0.54 (-0.32%) ▼|AAPL334.51+2.24 (+0.67%) ▲|ABBV261.43+4.31 (+1.68%) ▲|ABT102.95+1.00 (+0.98%) ▲|ACN194.28+10.38 (+5.64%) ▲|ADBE264.86+12.63 (+5.01%) ▲|AMAT426.96-29.53 (-6.47%) ▼|AMD494.09-22.05 (-4.27%) ▼|AMGN380.37+3.02 (+0.80%) ▲|AMT177.20-0.65 (-0.37%) ▼|AMZN255.59-1.19 (-0.46%) ▼|AVGO346.64-15.36 (-4.24%) ▼|AXP326.91+2.22 (+0.68%) ▲|BA210.37-0.09 (-0.04%) ▼|BAC60.11-2.59 (-4.12%) ▼|BKNG175.20+1.28 (+0.74%) ▲|BLK1,066.89-12.76 (-1.18%) ▼|BMY64.12+0.48 (+0.75%) ▲|BNY158.30-4.36 (-2.68%) ▼|BRK-B513.81+3.44 (+0.67%) ▲|C133.83-4.99 (-3.59%) ▼|CAT786.08-32.50 (-3.97%) ▼|CL88.34+1.54 (+1.77%) ▲|CMCSA24.98-0.22 (-0.87%) ▼|COF207.37-0.94 (-0.45%) ▼|COP137.69+0.34 (+0.25%) ▲|COST917.05+12.28 (+1.36%) ▲|CRM258.90+11.18 (+4.51%) ▲|CSCO111.49-0.65 (-0.58%) ▼|CVS95.67+1.01 (+1.07%) ▲|CVX213.68-0.39 (-0.18%) ▼|DE681.39+5.65 (+0.84%) ▲|DHR203.41+3.27 (+1.63%) ▲|DIS109.18+2.63 (+2.47%) ▲|DUK118.88-0.54 (-0.45%) ▼|EMR148.37-3.82 (-2.51%) ▼|FDX311.61+0.84 (+0.27%) ▲|GD356.78+0.88 (+0.25%) ▲|GE317.29-6.38 (-1.97%) ▼|GEV873.25-84.02 (-8.78%) ▼|GILD145.74+2.02 (+1.41%) ▲|GM86.41+0.79 (+0.92%) ▲|GOOG345.45+10.00 (+2.98%) ▲|GOOGL348.92+10.42 (+3.08%) ▲|GS990.42-38.76 (-3.77%) ▼|HD310.54+1.80 (+0.58%) ▲|HON199.12-3.25 (-1.60%) ▼|IBM250.89+7.60 (+3.12%) ▲|INTC98.29-4.66 (-4.52%) ▼|INTU338.38+16.81 (+5.23%) ▲|ISRG376.21+7.06 (+1.91%) ▲|JNJ267.88+2.30 (+0.87%) ▲|JPM349.21-7.02 (-1.97%) ▼|KO89.14+0.85 (+0.96%) ▲|LIN464.53-1.70 (-0.36%) ▼|LLY1,145.82+30.12 (+2.70%) ▲|LMT527.84+3.65 (+0.70%) ▲|LOW198.37+1.55 (+0.79%) ▲|LRCX275.82-22.41 (-7.51%) ▼|MA575.04+5.85 (+1.03%) ▲|MCD257.19+4.66 (+1.85%) ▲|MDLZ62.38-0.06 (-0.10%) ▼|MDT93.31+2.35 (+2.58%) ▲|META664.45+16.42 (+2.53%) ▲|MMM162.01-2.96 (-1.79%) ▼|MO70.55+1.57 (+2.27%) ▲|MRK145.46+1.53 (+1.06%) ▲|MS207.18-7.21 (-3.36%) ▼|MSFT509.20+13.57 (+2.74%) ▲|MU926.10-49.17 (-5.04%) ▼|NEE82.21-0.10 (-0.12%) ▼|NFLX80.75+3.35 (+4.32%) ▲|NKE37.15+0.35 (+0.94%) ▲|NOW143.13+10.60 (+7.99%) ▲|NVDA212.42-5.88 (-2.69%) ▼|ORCL143.85-6.44 (-4.28%) ▼|PEP136.61+0.29 (+0.21%) ▲|PFE27.78+0.06 (+0.20%) ▲|PG146.24+0.97 (+0.67%) ▲|PLTR173.30+6.07 (+3.63%) ▲|PM193.93+2.87 (+1.50%) ▲|QCOM179.12-2.85 (-1.57%) ▼|RTX194.66-3.03 (-1.53%) ▼|SBUX98.86+0.12 (+0.12%) ▲|SCHW106.98-0.27 (-0.25%) ▼|SO86.85-0.33 (-0.37%) ▼|SPG204.76-0.08 (-0.04%) ▼|T26.44+0.38 (+1.46%) ▲|TMO612.15+2.33 (+0.38%) ▲|TMUS183.99+1.66 (+0.91%) ▲|TSLA362.69-2.75 (-0.75%) ▼|TXN264.64-4.06 (-1.51%) ▼|UBER72.76+1.09 (+1.52%) ▲|UNH384.33+7.56 (+2.01%) ▲|UNP284.54+0.14 (+0.05%) ▲|UPS101.69+1.41 (+1.41%) ▲|USB62.38-0.46 (-0.73%) ▼|V376.34+5.89 (+1.59%) ▲|VZ51.30+0.69 (+1.35%) ▲|WFC87.69-2.60 (-2.88%) ▼|WMT109.49+2.34 (+2.18%) ▲|XOM165.46-0.54 (-0.32%) ▼|
22.2 C
New York
Monday, September 14, 2026

Tag: cause

newssourceFORcompanyinformationcontent1releasesmarket

MetrioPharm’s MP1032 Receives EMA Orphan Drug Designation in Duchenne Muscular Dystrophy

Zurich, July 29, 2025 – MetrioPharm AG, a pharmaceutical company developing drugs for inflammatory and infectious diseases, announced today that the European Medicines Agency has granted Orphan Drug Designation (ODD) to its lead compound, MP1032 for the treatment of children affected by Duchenne muscular dystrophy (DMD). This milestone follows the U.S. FDA's ODD, underscoring MP1032's potential as a first-in-class therapy that could minimize reliance on high-dose corticosteroids, which cause severe side effects like osteoporosis, growth stunting, and metabolic issues.

Progress on share buyback programme

Progress on share buyback programme

Orange: Financial results at 30 June 2025

Press release
Paris, 29 July 2025

Basilea initiates phase 3 study with antifungal fosmanogepix in invasive mold infections

Allschwil, Switzerland, July 29, 2025

Weekly progress on share repurchase program to cover share plans and reduce capital

Press Release

Questerre announces definitive agreement to acquire 100% of PX Energy

THIS NEWS RELEASE IS NOT FOR DISSEMINATION OR DISTRIBUTION IN THE UNITED STATES OF AMERICA TO UNITED STATES NEWSWIRE SERVICES OR UNITED STATES PERSONS

Pacific Valley Bancorp Announces Its Second Quarter 2025 Financial Results

SALINAS, Calif., July 28, 2025 /PRNewswire/ -- Pacific Valley Bancorp (OTC Pink: PVBK) announced its unaudited financial results for the second quarter of 2025. Net...

FDA Approves Apellis’ EMPAVELI® (pegcetacoplan) as the First C3G and Primary IC-MPGN Treatment for Patients 12 and Older

WALTHAM, Mass., July 28, 2025 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the U.S. Food and Drug Administration (FDA) has approved EMPAVELI® (pegcetacoplan) as the first treatment for C3 glomerulopathy (C3G) or primary immune complex membranoproliferative glomerulonephritis (IC-MPGN) in patients 12 years of age and older, to reduce proteinuria. C3G and primary IC-MPGN are rare kidney diseases, affecting 5,000 people in the United States.1

Regional Health Properties, Inc. Outlines Reasons for Regional Shareholders to Vote YES for Proposed Merger with SunLink Health Systems, Inc.

ATLANTA, GA, July 28, 2025 (GLOBE NEWSWIRE) -- Regional Health Properties, Inc. (“Regional”) (OTCBQ: RHEP) (OTCQB: RHEPA) (OTCQB: RHEPB), a self-managed healthcare real estate investment company that invests primarily in real estate purposed for senior living and long-term care, today issues the following statement to its common stock shareholders.

Invesque Inc. Completes Disposition of 11 Seniors Housing Assets and Manager Changes at Four Other Properties

TORONTO, July 28, 2025 /CNW/ - Invesque Inc. (the "Company" or "Invesque") (TSX: IVQ) (TSX: IVQ.U) announced today that over the last 40 days...

H2O America Announces Second Quarter 2025 Financial Results

H2O America reports second quarter 2025 financial results and hosts a live webcast on Tuesday, July 29, 2025 at 2 p.m. (ET).

Live Oak Bancshares, Inc. Prices Depositary Share Offering

WILMINGTON, N.C., July 28, 2025 (GLOBE NEWSWIRE) -- Live Oak Bancshares, Inc. (NYSE: LOB) (“Live Oak” or the “Company”) announced the pricing of an underwritten offering of 4,000,000 depositary shares, each representing a 1/40th ownership interest in a share of 8.375% Fixed Rate Series A Non-Cumulative Perpetual Preferred Stock (the “Series A Preferred Stock”), with a liquidation preference of $25 per depositary share.

GBank Financial Holdings Inc. Announces Second Quarter 2025 Financial Results

GBank Financial Holdings Inc. Announces Second Quarter 2025 Financial Results

BlackLine Appoints Greg Hughes to Board of Directors, Expanding Enterprise Software and Strategic Growth Expertise

LOS ANGELES, July 29, 2025 /PRNewswire/ -- BlackLine, Inc. (Nasdaq: BL), the future-ready financial operations platform for the Office of the CFO, today announced...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsCause

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers